These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 14668795)
1. Retinoic acid receptor alpha and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death. Pendino F; Dudognon C; Delhommeau F; Sahraoui T; Flexor M; Bennaceur-Griscelli A; Lanotte M; Ségal-Bendirdjian E Oncogene; 2003 Dec; 22(57):9142-50. PubMed ID: 14668795 [TBL] [Abstract][Full Text] [Related]
2. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization. Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843 [TBL] [Abstract][Full Text] [Related]
3. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation. Pendino F; Flexor M; Delhommeau F; Buet D; Lanotte M; Segal-Bendirdjian E Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6662-7. PubMed ID: 11371621 [TBL] [Abstract][Full Text] [Related]
4. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro. Shiohara M; Dawson MI; Hobbs PD; Sawai N; Higuchi T; Koike K; Komiyama A; Koeffler HP Blood; 1999 Mar; 93(6):2057-66. PubMed ID: 10068679 [TBL] [Abstract][Full Text] [Related]
5. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro. Kizaki M; Dawson MI; Heyman R; Elster E; Morosetti R; Pakkala S; Chen DL; Ueno H; Chao W; Morikawa M; Ikeda Y; Heber D; Pfahl M; Koeffler HP Blood; 1996 Mar; 87(5):1977-84. PubMed ID: 8634447 [TBL] [Abstract][Full Text] [Related]
6. Telomerase targeting by retinoids in cells from patients with myeloid leukemias of various subtypes, not only APL. Pendino F; Hillion J; Dudognon C; Delaunay J; Mourah S; Podgorniak MP; Lafon I; Chomienne C; Lanotte M; Dombret H; Rousselot P; Ségal-Bendirdjian E Leukemia; 2006 Apr; 20(4):599-603. PubMed ID: 16482212 [TBL] [Abstract][Full Text] [Related]
7. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma. Wan H; Hong WK; Lotan R Cancer Res; 2001 Jan; 61(2):556-64. PubMed ID: 11212249 [TBL] [Abstract][Full Text] [Related]
8. Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells. Duprez E; Lillehaug JR; Gaub MP; Lanotte M Oncogene; 1996 Jun; 12(11):2443-50. PubMed ID: 8649786 [TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha. Gianni' M; Kalaç Y; Ponzanelli I; Rambaldi A; Terao M; Garattini E Blood; 2001 May; 97(10):3234-43. PubMed ID: 11342454 [TBL] [Abstract][Full Text] [Related]
10. Regulation of CYP26A1 expression by selective RAR and RXR agonists in human NB4 promyelocytic leukemia cells. Idres N; Marill J; Chabot GG Biochem Pharmacol; 2005 Jun; 69(11):1595-601. PubMed ID: 15896339 [TBL] [Abstract][Full Text] [Related]
11. A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia cells through a defective pathway in telomerase regulation. Pendino F; Sahraoui T; Lanotte M; Ségal-Bendirdjian E Leukemia; 2002 May; 16(5):826-32. PubMed ID: 11986943 [TBL] [Abstract][Full Text] [Related]
12. Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells. Chattopadhyay N; Butters RR; Brown EM Brain Res Mol Brain Res; 2001 Feb; 87(1):100-8. PubMed ID: 11223164 [TBL] [Abstract][Full Text] [Related]
13. Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cells. Makishima M; Shudo K; Honma Y Biochem Pharmacol; 1999 Mar; 57(5):521-9. PubMed ID: 9952315 [TBL] [Abstract][Full Text] [Related]
14. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells. Lehmann S; Paul C; Törmä H Clin Cancer Res; 2001 Feb; 7(2):367-73. PubMed ID: 11234892 [TBL] [Abstract][Full Text] [Related]
15. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites. Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271 [TBL] [Abstract][Full Text] [Related]
16. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways. Dong S; Tweardy DJ Blood; 2002 Apr; 99(8):2637-46. PubMed ID: 11929748 [TBL] [Abstract][Full Text] [Related]
17. Critical role of both retinoid nuclear receptors and retinoid-X-receptors in mediating growth inhibition of ovarian cancer cells by all-trans retinoic acid. Wu S; Zhang D; Zhang ZP; Soprano DR; Soprano KJ Oncogene; 1998 Dec; 17(22):2839-49. PubMed ID: 9879990 [TBL] [Abstract][Full Text] [Related]